Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription 18.08.2025 2 Acta Ophthalmol 2 Biochem Biophys Res Commun 1 BMC Ophthalmol 4 BMJ 3 Diabet Med 3 Diabetes 4 Diabetes Care 10 Diabetes Obes Metab 3 Diabetologia 1 Invest Ophthalmol Vis Sci 6 J Clin Endocrinol Metab 1 J Diabetes Complications 1 J Immunol 1 N Engl J Med 1 Nutr Metab (Lond) 1 Ophthalmology 1 Pediatr Diabetes 12 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. ABU ISHKHEIDEM I, Breimer M, Kamal S, Zetterberg M, et al
   Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study.
   Acta Ophthalmol. 2025;103:699-706.
   PubMed         Abstract available
   
   
2. AMINI A, Hamann S, Larsen M
   Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.
   Acta Ophthalmol. 2025;103:615-621.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

3. BAVISKAR S, Agnihotri TG, Khopade S, Pati S, et al
   In silico investigation of human GLP-1 for diabetic nephropathy and in-vitro and in-vivo evaluation of its formulation.
   Biochem Biophys Res Commun. 2025;779:152445.
   PubMed         Abstract available
   
   
4. UMAR A, Khan MS, Hassan W, Ullah H, et al
   Pharmaceutical potential of cobalt iodide nanoparticles in enhancing wound healing and modulating endocrine, immune, metabolic and antibacterial functions.
   Biochem Biophys Res Commun. 2025;777:152320.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

5. SHEN Y, Zhu X, Li AQ, Ji M, et al
   Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema.
   BMC Ophthalmol. 2025;25:449.
   PubMed         Abstract available
   
   

   
   BMJ

6. THEODORAKI A
   Management of type 2 diabetes.
   BMJ. 2025;390:r1726.
   PubMed        
   
   
7. AGARWAL A, Mustafa R, Manja V, Agoritsas T, et al
   Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
   BMJ. 2025;390:e082071.
   PubMed         Abstract available
   
   
8. NONG K, Jeppesen BT, Shi Q, Agoritsas T, et al
   Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis.
   BMJ. 2025;390:e083039.
   PubMed         Abstract available
   
   
9. MISRA A, Sattar N, Ghosh A, Nassar M, et al
   Type 2 diabetes in South Asians.
   BMJ. 2025;390:e079801.
   PubMed         Abstract available
   
   

   
   Diabet Med

10. CHU L, Abitbol A
    Effect of switching from intermittently scanned to real-time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real-world, Canadian retrospective study.
    Diabet Med. 2025 Aug 9:e70119. doi: 10.1111/dme.70119.
    PubMed         Abstract available
    
    
11. FELEKE BE, Salim A, Magliano DJ, Shaw JE, et al
    Total and excess bed-days in people with diabetes in Australia.
    Diabet Med. 2025 Aug 11:e70118. doi: 10.1111/dme.70118.
    PubMed         Abstract available
    
    
12. RATHAN A, Boucsein A, Crocket H, Wheeler BJ, et al
    Continuous glucose monitoring remote monitoring does not meet the needs of all adult users: A qualitative study of adults with type 1 diabetes who do not use remote monitoring.
    Diabet Med. 2025 Aug 13:e70120. doi: 10.1111/dme.70120.
    PubMed         Abstract available
    
    

    
    Diabetes

13. HOSOE S, Katakami N, Taya N, Omori K, et al
    Association Between Myristic Acid in Plasma Triglycerides and Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: A Comprehensive Analysis of Plasma Lipids Using Supercritical Fluid Chromatography-Tandem Mass Spe
    Diabetes. 2025 Aug 14:db250099. doi: 10.2337/db25-0099.
    PubMed         Abstract available
    
    
14. DENG B, Nnebe C, Prakhar P, Ren X, et al
    New Insights Into Diabetes-Induced Cell-Type-Specific Responses in the Neural Retina via Single-Cell Transcriptomics: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2025 Aug 12:dbi240009. doi: 10.2337/dbi24-0009.
    PubMed         Abstract available
    
    
15. ZHOU X, Iakovliev A, McGurnaghan S, Erabadda B, et al
    Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.
    Diabetes. 2025 Aug 11:db250067. doi: 10.2337/db25-0067.
    PubMed         Abstract available
    
    

    
    Diabetes Care

16. MUNOZ-PARDEZA J, Hormazabal-Aguayo I, Huerta-Uribe N, Chueca-Guindulain MJ, et al
    Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial.
    Diabetes Care. 2025 Aug 13:dc250985. doi: 10.2337/dc25-0985.
    PubMed         Abstract available
    
    
17. WU Z, Liu B, Li J, Zeleznik O, et al
    Plasma Metabolome, Long-term Body Weight Change, and Type 2 Diabetes in U.S. Individuals.
    Diabetes Care. 2025 Aug 13:dc250902. doi: 10.2337/dc25-0902.
    PubMed         Abstract available
    
    
18. ZIEGLER J, Neu A, Ehehalt S, Schweizer R, et al
    Incidence of Type 1 Diabetes in Children Before, During, and After the COVID-19 Pandemic: 38-Year Analysis in Southwest Germany.
    Diabetes Care. 2025 Aug 12:dc251003. doi: 10.2337/dc25-1003.
    PubMed        
    
    
19. SAMAJDAR SS, Joshi SR
    The A-G Mnemonic: A Practical Framework for Deprescribing in Older Adults With Type 2 Diabetes.
    Diabetes Care. 2025 Aug 11:dc251348. doi: 10.2337/dc25-1348.
    PubMed        
    
    

    
    Diabetes Obes Metab

20. CHO YK, Cho JH, Hong SM, Park JH, et al
    Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial.
    Diabetes Obes Metab. 2025 Aug 14. doi: 10.1111/dom.70030.
    PubMed         Abstract available
    
    
21. BAJAJ HS, Bennedsen LV, Donatsky AM, Martiny JHJ, et al
    Adherence to app-based dose guidance for once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes: Post hoc analysis of ONWARDS 5.
    Diabetes Obes Metab. 2025 Aug 13. doi: 10.1111/dom.16597.
    PubMed         Abstract available
    
    
22. ANDERSEN JA, Suvitaival T, Trost K, Romero-Lado MJ, et al
    Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes.
    Diabetes Obes Metab. 2025 Aug 12. doi: 10.1111/dom.70001.
    PubMed         Abstract available
    
    
23. DEPOORTER L, Laghrib Y, De Fijter JW, Hellemans R, et al
    Diabetes screening in dialysis populations with a glucose challenge test and continuous glucose monitoring-DIGEST study.
    Diabetes Obes Metab. 2025 Aug 14. doi: 10.1111/dom.16656.
    PubMed         Abstract available
    
    
24. LI CE, Yang DW, Guo QQ
    Cardiac repolarization in type 1 diabetes: Considerations beyond the clamp.
    Diabetes Obes Metab. 2025 Aug 14. doi: 10.1111/dom.70042.
    PubMed        
    
    
25. ROSENSTOCK J, Robins DA, Duffin KL, Wilson JM, et al
    Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of beta-cell function and insulin sensitivity in type 2 diabetes.
    Diabetes Obes Metab. 2025 Aug 14. doi: 10.1111/dom.70022.
    PubMed         Abstract available
    
    
26. CARUSO I, Giordano F, Matichecchia II, Di Gioia L, et al
    Effectiveness of GLP-1RA according to different type 2 diabetes phenotypes: A retrospective study.
    Diabetes Obes Metab. 2025 Aug 11. doi: 10.1111/dom.70005.
    PubMed         Abstract available
    
    
27. CHANG H, Wang R
    Screening for type 1 diabetes in patients with celiac or thyroid disease: Practical considerations.
    Diabetes Obes Metab. 2025 Aug 11. doi: 10.1111/dom.70018.
    PubMed        
    
    
28. GEORGIANOS PI, Koufakis T, Arampatzis S, Liakopoulos V, et al
    CONFIDENCE in the safety and efficacy of dual therapy with an SGLT-2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes.
    Diabetes Obes Metab. 2025 Aug 11. doi: 10.1111/dom.70026.
    PubMed        
    
    
29. MALIK RA, Anderson J, Russo G, Amani MEA, et al
    Long-term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli-durability 24-month observational study.
    Diabetes Obes Metab. 2025 Aug 11. doi: 10.1111/dom.16591.
    PubMed         Abstract available
    
    

    
    Diabetologia

30. KENNEDY B, Wernroth ML, Langenskiold S, Bonander C, et al
    The impact of child type 1 diabetes on parental incomes in a welfare state context: quasi-experimental evidence from Swedish national registers.
    Diabetologia. 2025 Aug 8. doi: 10.1007/s00125-025-06492.
    PubMed         Abstract available
    
    
31. MYTKOLLI L, Ahmed A, Ajmal S, Alvarez Pagola A, et al
    Diabetes in four dialects: a global call for equity across lived, loved, learned and laboured experiences.
    Diabetologia. 2025 Aug 9. doi: 10.1007/s00125-025-06506.
    PubMed        
    
    
32. HERDER C, Pritlove C, Chaturvedi N, Mulder H, et al
    Diabetes prevention and treatment: a global perspective.
    Diabetologia. 2025 Aug 12. doi: 10.1007/s00125-025-06511.
    PubMed        
    
    

    
    Invest Ophthalmol Vis Sci

33. VON SCHULTHESS EL, Maunz A, Chakravarthy U, Holekamp N, et al
    Author Response: Letter to the Editor Regarding "Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema".
    Invest Ophthalmol Vis Sci. 2025;66:36.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

34. 
    Correction to: "A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy".
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf441. doi: 10.1210.
    PubMed        
    
    
35. IGUDESMAN D, Nally LM, Grimshaw AA, Gunderson CG, et al
    Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials.
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf448. doi: 10.1210.
    PubMed         Abstract available
    
    
36. DEL PRATO S, Bonadonna RC
    Glucagon: The Arab Phoenix of the Complex Pathophysiology of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf421. doi: 10.1210.
    PubMed        
    
    
37. SEVILLA-GONZALEZ M, Hanson PA, Islam J, Hsu S, et al
    Compartment-Specific Metabolic Alterations to Insulin Reflect Adiposity-Driven Variation and Predict Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf454. doi: 10.1210.
    PubMed         Abstract available
    
    
38. YANG Y, Wang JH, Wang HA, Zhang TP, et al
    Blood plasma proteome-wide association study implicates new proteins in type 2 diabetes mellitus pathogenesis.
    J Clin Endocrinol Metab. 2025 Aug 12:dgaf462. doi: 10.1210.
    PubMed         Abstract available
    
    
39. LIN YT, Sayols-Baixeras S, Graells T, Dekkers KF, et al
    Identification of gut microbiome signatures and metabolites associated with albuminuria in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Aug 14:dgaf453. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

40. MUZUROVIC E, Topic G, Todorovic N, Rizzo M, et al
    The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.
    J Diabetes Complications. 2025;39:109147.
    PubMed         Abstract available
    
    

    
    J Immunol

41. RACINE JJ, Dwyer JR, Chapman HD, Bell A, et al
    Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protection.
    J Immunol. 2025 Aug 12:vkaf189. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    N Engl J Med

42. HALES CM
    Expanding the Treat-to-Target Toolbox for Obesity and Diabetes Care.
    N Engl J Med. 2025;393:712-714.
    PubMed        
    
    

    
    Nutr Metab (Lond)

43. HAN T, Liang X, Liu H, Zhu M, et al
    Muscle-building interventions improve glucose metabolism in elderly type 2 diabetic patients with sarcopenic obesity.
    Nutr Metab (Lond). 2025;22:98.
    PubMed         Abstract available
    
    

    
    Ophthalmology

44. NANJI K, Grad J, Hatamnejad A, El-Sayes A, et al
    Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
    Ophthalmology. 2025 Aug 11:S0161-6420(25)00483.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

45. SCHWEIZER R, Bung JI, Majer D, Liebrich F, et al
    Celiac Disease in Children With Type 1 Diabetes: The Usefulness of Screening- 25 years of Experience in a Single Center.
    Pediatr Diabetes. 2025;2025:4717290.
    PubMed         Abstract available
    
    

    
    PLoS One

46. TU G, Cai Z, Wu L, Yu H, et al
    Predicting in-hospital mortality in ICU patients with Coronary heart disease and diabetes mellitus using machine learning models.
    PLoS One. 2025;20:e0330381.
    PubMed         Abstract available
    
    
47. ZHANG JX, Meltzer DO
    Longitudinal progression of cost-related medication non-adherence among Medicare patients with diabetes at high risk of hospitalization: The role of dual eligibility.
    PLoS One. 2025;20:e0329031.
    PubMed         Abstract available
    
    
48. ZENAW A, Chane E, Fetene G, Wondifraw H, et al
    Hypogonadism and its associated factors among adult male type 2 diabetes mellitus patients at the university of gondar comprehensive specialized hospital, Northwest Ethiopia 2024: A comparative cross-sectional study.
    PLoS One. 2025;20:e0329784.
    PubMed         Abstract available
    
    
49. CHEN S, Guo L, Ma X, Wang S, et al
    Association between Endothelial Activation and Stress Index and mortality in diabetic nephropathy ICU patients: A retrospective cohort study.
    PLoS One. 2025;20:e0329233.
    PubMed         Abstract available
    
    
50. NORTEY E, Derkyi-Kwarteng L, Amoako-Sakyi D, Bockarie AS, et al
    Galectin-3 did not associate with malaria-related insulin resistance in diabetic and non-diabetic respondents at a Ghanaian General Hospital.
    PLoS One. 2025;20:e0330068.
    PubMed         Abstract available
    
    
51. VINCENTINI O, Pricci F, Silano M, Agrimi U, et al
    Study protocol of D1Ce Screen: A pilot project of the Italian national screening program for type 1 diabetes and coeliac disease in the paediatric population.
    PLoS One. 2025;20:e0328624.
    PubMed         Abstract available
    
    
52. AN W, Guo D, Wang J, Chu X, et al
    Effects of non-pharmacological interventions on cognitive function in patients with type 2 diabetes mellitus and mild cognitive impairment: A network meta-analysis.
    PLoS One. 2025;20:e0329397.
    PubMed         Abstract available
    
    
53. RASMUSSEN MGB, Just-Ostergaard E, Stidsen JV, Willaing I, et al
    What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.
    PLoS One. 2025;20:e0329394.
    PubMed         Abstract available
    
    
54. AZHAR G, Verma A, Patyal P, Zhang W, et al
    Differential microRNA profiling of the Marshallese population in Arkansas reveals a higher association with chronic diseases.
    PLoS One. 2025;20:e0329321.
    PubMed         Abstract available
    
    
55. PIENKOWSKA A, Car J, Best J, Koh CHG, et al
    Real-world clinical practice of Diabetic Foot Ulcer prevention and care in Singapore: A qualitative inquiry with healthcare professionals.
    PLoS One. 2025;20:e0328637.
    PubMed         Abstract available
    
    
56. ONG R, Ng CJ, Gunasekaran K, Liu H, et al
    Correction: Utility of a patient similarity-based digital tool for risk communication to patients with type 2 diabetes mellitus: Perspectives from primary care physicians in ambulatory care.
    PLoS One. 2025;20:e0330120.
    PubMed         Abstract available
    
    
57. OROMO DO, Melaku AM
    Correction: Pediatric Diabetic Ketoacidosis (PDKA) among newly diagnosed diabetic patients at Dilla University Hospital, Dilla, Ethiopia: Prevalence and predictors.
    PLoS One. 2025;20:e0330202.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

58. PALLAVI A, Sinha N, ArunKumar NK, Kothegala L, et al
    Dynamic GLUT trafficking at high glucose levels enhances insulin secretion: Dysregulation leads to decreased insulin secretion during type 2 diabetes.
    Proc Natl Acad Sci U S A. 2025;122:e2425955122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.